Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Sinarmas Multiartha Tbk. (SMMA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Sinarmas Multiartha Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 7.6K 24h volume), while Sinarmas Multiartha Tbk. trades at Rp20,175 (market cap 128.47T). The key difference: Sinarmas Multiartha Tbk. is far larger — about 402.7× Diagnos Laboratorium Utama Tbk.'s market cap. Which is the better fit depends on your goals.
| DGNS | SMMA | |
|---|---|---|
Market Cap | 319B | 128.47T |
Volume | 7.6K | — |
Lot | 76 | — |
Turnover | 1.74M | — |
Average Price | 229.21 | — |
Value | 1.74M | — |
Indicative Equilibrium Price | 232 | — |
Indicative Equilibrium Volume | 200 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Sinarmas Multiartha Tbk.
PT Sinar Mas Multiartha Tbk was established by Deed No. 60 dated October 21, 1982 from Benny Kristianto, S.H., notary in Jakarta. PT Sinar Mas Multiartha was initially active in commercial leasing, consumer financing and venture capital, and purely became a holding company in the Sinar Mas Group.
Read more on SMMA →
